• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵犯主动脉或上腔静脉的肺癌的外科治疗

Surgical management of lung cancer invading the aorta or the superior vena cava.

作者信息

Misthos P, Papagiannakis G, Kokotsakis J, Lazopoulos G, Skouteli E, Lioulias A

机构信息

Sismanogleio General Hospital, Thoracic Surgery Department, Athens, Greece.

出版信息

Lung Cancer. 2007 May;56(2):223-7. doi: 10.1016/j.lungcan.2006.12.008. Epub 2007 Jan 16.

DOI:10.1016/j.lungcan.2006.12.008
PMID:17229487
Abstract

OBJECTIVE

Invasion of mediastinal structures (T4) is considered as an absolute contraindication to surgical management of non-small cell lung cancer (NSCLC). The authors studied the role of surgical treatment in case of direct aortic and superior venous caval involvement.

PATIENTS

From 1995 to 2000, 13 patients with left lung NSCLC invading descending aorta and 9 patients with right upper lobe NSCLC and superior vena cava (SVC) invasion were subjected to thoracotomy for lung resection. Surgery was indicated in case of absence of intraluminal extension. All patients were cN2 negative. The pathology results and 5-year survival were recorded and analyzed.

RESULTS

In three cases (23%) the tumor was adhered to the parietal pleura overlying descending aorta, which was resected en block with tumor-associated lung parenchyma. Aortic adventitia invasion by tumor led to local resection of adventitia (<1cm(2)) in nine patients (69%). Invasion deeper than adventitia was encountered in one case (8%), which was managed with aortic partial occlusion, resection of aortic wall and repair of the defect with Gore graft patch. In three patients (33%) the SVC wall was involved by the tumor 1-3cm in length and 2-4mm of the circumference. The defect was repaired with direct suturing. In five patients (56%) the area of SVC wall that was invaded was 3cmx2cm. The defect was repaired with Dacron patch. In 1 patient (11%) an arterial 14 graft was end-to-end interposed. All resections were radical (R0). Neither associated postoperative complications nor operative mortality was recorded. Five-year survival was 30.7% for the cases with aortic invasion and 11% for the ones with SVC involvement.

CONCLUSIONS

Radical surgical resection of lung tumors with localized aortic invasion can be considered after exclusion of N2 involvement.

摘要

目的

纵隔结构侵犯(T4)被视为非小细胞肺癌(NSCLC)手术治疗的绝对禁忌证。作者研究了在主动脉和上腔静脉直接受累情况下手术治疗的作用。

患者

1995年至2000年,13例左肺NSCLC侵犯降主动脉以及9例右上叶NSCLC侵犯上腔静脉(SVC)的患者接受了开胸肺切除术。若不存在腔内扩展则考虑手术。所有患者cN2均为阴性。记录并分析病理结果和5年生存率。

结果

3例(23%)肿瘤与覆盖降主动脉的脏层胸膜粘连,与肿瘤相关的肺实质一并整块切除。9例(69%)患者肿瘤侵犯主动脉外膜,导致外膜局部切除(<1cm²)。1例(8%)患者侵犯深度超过外膜,采用主动脉部分阻断、主动脉壁切除并用戈尔补片修复缺损处理。3例(33%)患者SVC壁受肿瘤侵犯,长度为1 - 3cm,圆周范围为2 - 4mm。缺损采用直接缝合修复。5例(56%)患者SVC壁受侵犯面积为3cm×2cm。缺损采用涤纶补片修复。1例(11%)患者行端端插入动脉移植物。所有切除均为根治性(R0)。未记录到相关术后并发症及手术死亡率。主动脉侵犯病例的5年生存率为30.7%,SVC受累病例为11%。

结论

排除N2受累后,可考虑对局限性主动脉侵犯的肺肿瘤进行根治性手术切除。

相似文献

1
Surgical management of lung cancer invading the aorta or the superior vena cava.侵犯主动脉或上腔静脉的肺癌的外科治疗
Lung Cancer. 2007 May;56(2):223-7. doi: 10.1016/j.lungcan.2006.12.008. Epub 2007 Jan 16.
2
15 years single center experience with surgical resection of the superior vena cava for non-small cell lung cancer.15年单中心非小细胞肺癌上腔静脉手术切除经验。
Lung Cancer. 2004 Sep;45(3):357-63. doi: 10.1016/j.lungcan.2004.02.009.
3
Results of superior vena cava resection for lung cancer. Analysis of prognostic factors.肺癌上腔静脉切除的结果。预后因素分析。
Lung Cancer. 2004 Jun;44(3):339-46. doi: 10.1016/j.lungcan.2003.11.010.
4
Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion.肺癌合并上腔静脉切除术:上腔静脉侵犯模式的预后意义
Ann Thorac Surg. 2004 Oct;78(4):1184-9; discussion 1184-9. doi: 10.1016/j.athoracsur.2004.04.066.
5
Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.单中心25年间T4期非小细胞肺癌的初次手术结果:获益值得冒险。
Ann Thorac Surg. 2008 Oct;86(4):1065-75; discussion 1074-5. doi: 10.1016/j.athoracsur.2008.07.004.
6
Chest wall invasion in non-small cell lung carcinoma: a rationale for en bloc resection.非小细胞肺癌胸壁侵犯:整块切除的理论依据
J Thorac Cardiovasc Surg. 2001 Apr;121(4):649-56. doi: 10.1067/mtc.2001.112826.
7
Review of superior vena cava resection in the management of benign disease and pulmonary or mediastinal malignancies.上腔静脉切除术在良性疾病以及肺部或纵隔恶性肿瘤治疗中的应用综述
Ann Thorac Surg. 2009 Aug;88(2):392-7. doi: 10.1016/j.athoracsur.2009.04.068.
8
Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.上腔静脉切除术治疗肺和纵隔恶性肿瘤:单中心70例经验
Ann Thorac Surg. 2007 Jan;83(1):223-9; discussion 229-30. doi: 10.1016/j.athoracsur.2006.07.075.
9
[Surgical results of T4 lung cancer invading left atrium and great vessels].[侵犯左心房及大血管的T4期肺癌的手术结果]
Zhonghua Yi Xue Za Zhi. 2008 Feb 5;88(6):383-6.
10
Surgical treatment of IIIb-T4 lung cancer invading left atrium and great vessels.IIIb-T4 期肺癌侵犯左心房和大血管的外科治疗。
Chin Med J (Engl). 2010 Feb 5;123(3):265-8.

引用本文的文献

1
A Systematic Review of Surgical Strategies for Managing Major Thoracic Vessels in Thoracic Oncology.胸科肿瘤学中处理主要胸段血管的手术策略的系统评价
Ann Surg Oncol. 2025 Mar 17. doi: 10.1245/s10434-025-17159-2.
2
Investigating the predictive factors of thoracic aortic invasion and surgical outcomes in patients with primary lung cancer: A retrospective study.探讨原发性肺癌患者胸主动脉侵犯的预测因素及手术结果:一项回顾性研究。
Thorac Cancer. 2024 May;15(15):1263-1270. doi: 10.1111/1759-7714.15311. Epub 2024 Apr 16.
3
T4 Lung Carcinoma with Infiltration of the Thoracic Aorta: Indication and Surgical Procedure.
伴有胸主动脉浸润的T4期肺癌:适应症及手术方法
Cancers (Basel). 2023 Oct 4;15(19):4847. doi: 10.3390/cancers15194847.
4
Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review.肺癌侵犯上腔静脉——外科治疗。简短的最新综述。
Kardiochir Torakochirurgia Pol. 2023 Jun;20(2):105-110. doi: 10.5114/kitp.2023.129546. Epub 2023 Jul 26.
5
A Multicenter Retrospective Cohort Study on Superior Vena Cava Resection in Non-Small-Cell Lung Cancer Surgery.非小细胞肺癌手术中 superior vena cava 切除术的多中心回顾性队列研究。 (注:superior vena cava 一般译为“上腔静脉” )
Cancers (Basel). 2022 Dec 13;14(24):6138. doi: 10.3390/cancers14246138.
6
Cardiopulmonary bypass does not consequentially contribute to postoperative distant metastasis of giant refractory thoracic tumors: A retrospective study with long-term follow-up.体外循环不会导致巨大难治性胸壁肿瘤术后远处转移:一项长期随访的回顾性研究。
Thorac Cancer. 2021 Nov;12(22):2990-2995. doi: 10.1111/1759-7714.14162. Epub 2021 Sep 16.
7
Preliminary evaluation and discussion of the safety of left innominate vein resection.左无名静脉切除术安全性的初步评估与讨论
J Thorac Dis. 2020 Mar;12(3):438-447. doi: 10.21037/jtd.2020.01.29.
8
Chest wall/parietal pleural invasions worsen prognosis in T4 non-small cell lung cancer patients after resection.胸壁/脏层胸膜侵犯会使T4期非小细胞肺癌患者术后的预后恶化。
Gen Thorac Cardiovasc Surg. 2019 Sep;67(9):788-793. doi: 10.1007/s11748-019-01093-8. Epub 2019 Feb 21.
9
Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?根据影像学检查结果,对侵犯相邻大血管的不可切除非小细胞肺癌进行同步放化疗:是否安全?
J Radiat Res. 2019 Mar 1;60(2):234-241. doi: 10.1093/jrr/rry102.
10
Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?T4期非小细胞肺癌的初始扩大切除术或新辅助治疗——证据是什么?
Shanghai Chest. 2018 Oct;2. doi: 10.21037/shc.2018.09.08. Epub 2018 Oct 11.